<- Go Home
Calmare Therapeutics Incorporated
Calmare Therapeutics Incorporated, a medical device company, develops and commercializes products and technologies for chronic neuropathic pain and wound care affliction patients in the United States. Its flagship medical device is Calmare Pain Therapy Device, a non-invasive and non-addictive modality for the treatment of chronic and neuropathic pain. The company was formerly known as Competitive Technologies, Inc. and changed its name to Calmare Therapeutics Incorporated in August 2014. Calmare Therapeutics Incorporated was founded in 1968 and is based in Fairfield, Connecticut.
Market Cap
$38.00
Volume
19.2K
Cash and Equivalents
$12.6K
EBITDA
-$2.4M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$771.5K
Profit Margin
67.39%
52 Week High
$0.02
52 Week Low
$0.00
Dividend
N/A
Price / Book Value
-0.00
Price / Earnings
-0.00
Price / Tangible Book Value
-0.00
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-$2.5M
Return on Equity
31.61%
Return on Assets
-37.85
Cash and Short Term Investments
$12.6K
Debt
$5.9M
Equity
-$13.8M
Revenue
$1.1M
Unlevered FCF
$234.7K
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium